Your browser doesn't support javascript.
loading
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.
Mrak, Daniel; Simader, Elisabeth; Sieghart, Daniela; Mandl, Peter; Radner, Helga; Perkmann, Thomas; Haslacher, Helmuth; Mayer, Margareta; Koblischke, Maximilian; Hofer, Philipp; Göschl, Lisa; Kartnig, Felix; Deimel, Thomas; Kerschbaumer, Andreas; Hummel, Thomas; Kornek, Barbara; Thalhammer, Renate; Stiasny, Karin; Winkler, Stefan; Smolen, Josef S; Aberle, Judith H; Aletaha, Daniel; Heinz, Leonhard X; Bonelli, Michael.
Afiliação
  • Mrak D; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Simader E; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Sieghart D; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Mandl P; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Radner H; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Perkmann T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Mayer M; Center for Virology, Medical University of Vienna, Vienna, Austria.
  • Koblischke M; Center for Virology, Medical University of Vienna, Vienna, Austria.
  • Hofer P; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Göschl L; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kartnig F; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Deimel T; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kerschbaumer A; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Hummel T; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kornek B; 2nd Department of Medicine, Lower Austrian Competence Center for Rheumatology, Landesklinikum Stockerau, Stockerau, Lower Austria, Austria.
  • Thalhammer R; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Stiasny K; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Winkler S; Center for Virology, Medical University of Vienna, Vienna, Austria.
  • Smolen JS; Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Aberle JH; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Aletaha D; Center for Virology, Medical University of Vienna, Vienna, Austria.
  • Heinz LX; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Bonelli M; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Ann Rheum Dis ; 81(12): 1750-1756, 2022 12.
Article em En | MEDLINE | ID: mdl-35977809
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2022 Tipo de documento: Article